COVAXX gets supply deals worth $2.8 billion for potential Covid-19 vaccine
COVAXX, a unit of United Biomedical Inc, said on Thursday it has received purchase commitments totaling $2.8 billion to deliver more than 140 million doses of its potential Covid-19 vaccine to developing countries, including Brazil, Peru and Ecuador.
The multitope peptide-based vaccine is currently in early-stage trials in Taiwan, lagging some of the frontrunners in the race to develop a safe and effective vaccine.
The US based company signed an agreement in September with Brazilian lab and hospital group DASA S.A. to conduct mid-to-late stage trials in Brazil for the vaccine.
COVAXX estimates it can produce 100 million doses in first half of next year and 1 billion by end of 2021.
Last month, the company signed a logistics partnership with Maersk for transportation and supply chain services that will be needed to deliver the vaccine around the world.
Enter your email to get our daily newsletter in your inbox
- Ignoring the continuous protests by the workers of the plant, the Centre has begun the exercise of disinvestment in the steel plant.
- According to the report, bookings surged in Goa for both February 15 and February 22 by over 20%.
- Here are today’s top news, analysis, and opinion. Know all about the latest news and other news updates from Hindustan Times.
- A green Scorpio SUV was found parked on Carmichael Road some 600 meters away from Mukhesh Ambani’s residence Antila on Altamount Road.